Published on:

Ekso Bionics Holdings: Class Action

By

Ekso Bionics Holdings

Publicly available records indicate that a class action lawsuit has been filed on behalf of investors in Ekso Bionics Holdings (NASDAQ:EKSO) in connection to alleged violations of securities laws by EKSO. Fitapelli Kurta is interested in speaking to investors who have complaints regarding investments made in Ekso Bionics Holdings from March 15, 2017 until December 27, 2017.

The class action complaint specifically alleges that during the period in question, EKSO might have provided false and/or misleading material information, and/or failed to disclose adverse material information, chiefly: that the company’s internal systems governing financial reporting suffered from a material weakness; that the company had inadequate controls and procedures governing disclosure; and that consequently the company’s statements to the public during the relevant period were false and misleading. The complaint alleges that when true facts emerged, investors suffered losses.

According to the company’s website, Ekso Bionics Holdings is “a worldwide pioneer in the field of robotic exoskeletons” that develops wearable exoskeleton technologies. Its products have applications in medical and industrial markets, according to the website, and help to enhance “human strength, endurance, and mobility potential.” These include the EksoGT, an FDA-approved exoskeleton for rehabilitation from strokes and spinal cord injuries; SmartAssist, which “promotes early mobility with training, flexible controls, and a rehabilitation friendly user-interface”; FES, which uses electrical currents to stimulate nerves and cause muscular contraction, enabling muscle training even in cases where the patient has lost some or all voluntary muscle control; and EksoPulse, a cloud platform for physical therapists and physicians. The company is headquartered in North Carolina and trades on the Nasdaq exchange under the symbol EKSO.

A class action lawsuit has already been filed in connection with Ekso Bionics Holdings. If you wish to serve as lead plaintiff in the EKSO lawsuit, you must move the Court no later than March 5, 2018. If you wish to join the litigation, please contact Marc Fitapelli at 212-658-1501 or Jonathan Kurta at 212-658-1502. There is no cost or obligation to you and your ability to share in any recovery does not require that you serve as a lead plaintiff.